Search research articles
Contact Us
Filters
Showing results (41-50 of 71) with videos related to
Page
of 8
Sort By:
Cancer Treatment Reports
|
September 1, 1977
BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphoma
J R Durant, R A Gams, A A Bartolucci, et al.
Cancer
|
March 1, 1975
The pathologic behavior of primary vaginal carcinoma and its relationship to cervical cancer
T M Murad, J R Durant, W A Maddox, et al.
Cancer Clinical Trials
|
January 1, 1980
A murine plasmacytoma model for screening active drugs for human myeloma
R N Hiramoto, V K Ghanta, J R Durant, et al.
American Journal of Hematology
|
January 1, 1980
Provoked priapism in sickle cell anemia
M E Conrad, G M Perrine, J C Barton, et al.
American Journal of Clinical Oncology
|
February 1, 1985
Tumor burden, chemotherapy, and cell kill in osteosarcoma model
R N Hiramoto, V K Ghanta, S J Soong, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 1, 1981
A practical system for clinical radiofrequency hyperthermia
I A Brezovich, M B Lilly, J R Durant, et al.
Annals of Internal Medicine
|
December 1, 1982
Inflammatory fibrous histiocytoma: an important variant of malignant fibrous histiocytoma highly responsive to chemotherapy
M C Poon, J R Durant, M J Norgard, et al.
Cancer Treatment Reports
|
June 1, 1976
Southeastern Cancer Study Group trials with nitrosoureas in Hodgkin's disease
J R Durant, A Bartolucci, R A Gams, et al.
Cancer
|
August 1, 1979
The superiority of combination chemotherapy over single agent chemotherapy in small cell lung carcinoma
S Lowenbraun, A Bartolucci, R V Smalley, et al.
Cancer Clinical Trials
|
January 1, 1981
Assessment of myeloma maintenance regimen of prednisone. Adriamycin, imuran, and vincristine in a murine plasmacytoma model
V K Ghanta, H J Cohen, H R Silberman, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 71) with videos related to
Sort By:
Page
of 8
Cancer Treatment Reports
|
September 1, 1977
BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphoma
J R Durant, R A Gams, A A Bartolucci, et al.
Cancer
|
March 1, 1975
The pathologic behavior of primary vaginal carcinoma and its relationship to cervical cancer
T M Murad, J R Durant, W A Maddox, et al.
Cancer Clinical Trials
|
January 1, 1980
A murine plasmacytoma model for screening active drugs for human myeloma
R N Hiramoto, V K Ghanta, J R Durant, et al.
American Journal of Hematology
|
January 1, 1980
Provoked priapism in sickle cell anemia
M E Conrad, G M Perrine, J C Barton, et al.
American Journal of Clinical Oncology
|
February 1, 1985
Tumor burden, chemotherapy, and cell kill in osteosarcoma model
R N Hiramoto, V K Ghanta, S J Soong, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 1, 1981
A practical system for clinical radiofrequency hyperthermia
I A Brezovich, M B Lilly, J R Durant, et al.
Annals of Internal Medicine
|
December 1, 1982
Inflammatory fibrous histiocytoma: an important variant of malignant fibrous histiocytoma highly responsive to chemotherapy
M C Poon, J R Durant, M J Norgard, et al.
Cancer Treatment Reports
|
June 1, 1976
Southeastern Cancer Study Group trials with nitrosoureas in Hodgkin's disease
J R Durant, A Bartolucci, R A Gams, et al.
Cancer
|
August 1, 1979
The superiority of combination chemotherapy over single agent chemotherapy in small cell lung carcinoma
S Lowenbraun, A Bartolucci, R V Smalley, et al.
Cancer Clinical Trials
|
January 1, 1981
Assessment of myeloma maintenance regimen of prednisone. Adriamycin, imuran, and vincristine in a murine plasmacytoma model
V K Ghanta, H J Cohen, H R Silberman, et al.
Page
of 8